CW May 2004Issue Number 5 May 2004 ISSN 10593802 Therion Biologics Initiates Phase III Trials with Pancreatic Cancer VaccineTherion Biologics Company, Cam-bridge, MA targets to launch a phase III trial of a cancer vaccine for the treatment of metastatic pancreatic cancer for chemotherapy-resistant patients this summer.
Go to Previous Page Source & Additional Reading (Study results) American Society of Clinical Oncology (ASCO) in New Orleans, June 7, 2004 Purchase Downloadable Full-text PDF of Article: $10.00 Subscription is more cost effective than purchasing PDFs on-the-fly. Click here for details. Download Complete Issue CW May 2004Purchase Downloadable Full-text PDF of Complete Issue: $20.00 |
|
Member Login | Home | Offices | Subscribe | Glossary | Cancer Technologies | Contact Us
Adenine Press, 2066 Central Avenue, Schenectady, NY 12304 USA |
Re-initialize IP-based Login |